Under construction – not a live service
Sign in
Taking people in PolandNo phase

iStent Inject Versus Goniotomy With Kahook Dual Blade in Glauocma Treatment

Key facts

Where
Bialystok, PolandSee the 2 sites

Where in Poland

  • Medical University of BialystokBialystok, PolandTaking people
  • Ophthalmology Clinic Medical University of BialystokBialystok, PolandTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Medical University of Bialystok
Trial code
NCT07325552
Record updated
8 January 2026
Original description
The purpose of the study is to investigate the efficacy of cataract surgery in combination with Kahook Dual Blade Glide goniotomy (KDB) or iStent Inject W Trabecular Microbypass Stent (Istent) in eyes with Open-angle glaucoma.Read full original descriptionShow less

iStent Inject Versus Goniotomy With Kahook Dual Blade in Patients With Ocular Hypertension and Glaucoma

The purpose of the study is to investigate the efficacy of cataract surgery in combination with Kahook Dual Blade Glide goniotomy (KDB) or iStent Inject W Trabecular Microbypass Stent (Istent) in eyes with Open-angle glaucoma.

Inclusion: Only one eye per participant; Clinically significant cataract; Glaucoma or intraocular hypertension treated with one to four medications and no need for filtering glaucoma surgery at the time of study enrollment; Open chamber angle with Schaffer grading three to four in at least two quadrants.

Exclusion: Previous glaucoma surgery, including cyclodestructive procedures; Selective Laser Trabeculoplasty (SLT) within 90 days prior to planned surgery; Unable to participate and make written consent due to another medical condition; Exudative age-related macular degeneration, proliferative diabetic retinopathy, clinically significant corneal dystrophy, other eye disease that affect intraocular eye pressure or visual field.

ClinicalTrials.gov NCT07325552